Nerivio: From price to efficacy, all you need to know about drug-free cure for migraine

livemint.com:

USFDA approved device to use Remote Electrical Neuromodulation (REN) to prevent and treat migraine," the drug maker said in a press release. "The rollout of Nerivio marks our entry into digital therapeutics. It is an area that is seeing increasing adoption by physicians as well as patients due to its potential to reduce pill burden and decrease dependency on non-specific medication in chronic or hard-to-treat diseases," Dr Reddy’s CEO Branded Markets (India and Emerging Markets) MV Ramana said.

Here's all you need to know about Nerivio, the drug-free cure for migraine: Dr Reddy’s Laboratories said Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migraine. The drug-maker said the device is for people aged 12 years and above. "Nerivio® is suitable for a wide range of patients, including those who prefer drug-free options, individuals with contraindications to medications or poor medication tolerance, sensitive populations such as adolescents, women of vulnerable age groups and patients at risk of medication overuse headaches," it added.

Dr Reddy's said Nerivio® proved "efficacy in not only effectively treating relief of pain but also associated symptoms in migraine such as nausea, vomiting etc. It has been shown to reduce the need for drugs used for acute treatment in nearly nine out of 10 patients". According to a Times of India report, Nerivio has been priced at ₹14,000-16,000.